Diclofenac potassium
- Level
- Commodity
- Parent
- 51383300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51383314This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H10Cl2NO2.K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L4D5UA6CB4, chemically known as 2-((2,6-dichlorophenyl)amino)benzeneacetic acid but more generally known as diclofenac potassium, which bears US NIH Compound Identifier 3033. European Medicines Agency schedules Diclofenac potassium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13568MIG. Most nations, for tariff and trade purposes, schedule diclofenac potassium under HS 29224995 and SITC 51465. As of Q4 2014, DICLOFENAC POTASSIUM remains US FDA's Preferred Term for this commodity. Diclofenac potassium bears US NLM identifiers UMLS ID C0282131 and NCI Concept Code C47983. SMILES: C1CCC(C(C1)CC(=O)[O-])NC2C(CCCC2CL)CL.[K+].
Same parent
Under 51383300 · 17Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.